Search Results - "Petrić Miše, B."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study by Vrdoljak, J, Boban, T, Petrić Miše, B, Boraska Jelavić, T, Bajić, Ž, Tomić, S, Vrdoljak, E

    Published in Japanese journal of clinical oncology (01-04-2019)
    “…The optimal first-line therapy of advanced ovarian cancer still remains questionable: standard paclitaxel-carboplatin (TC), dose-dense TC, intraperitoneal…”
    Get full text
    Journal Article
  2. 2

    Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas by Sundov, D, Petric Mise, B, Mrklic, I, Bacic, B, Vrdoljak, E, Tomic, S

    Published in Neoplasma (2017)
    “…Ovarian cancer accounts for only 3% of all cancers in women but is the most lethal gynaecologic malignancy. Low-grade and high-grade ovarian serous carcinomas…”
    Get more information
    Journal Article
  3. 3

    Optimisation of breast cancer patients' follow‐up – potential way to improve cancer care in transitional countries by Bošković, L., Gašparić, M., Petrić Miše, B., Petković, M., Gugić, D., Ban, M., Jazvić, M., Dabelić, N., Belac Lovasić, I., Vrdoljak, E.

    Published in European journal of cancer care (01-07-2017)
    “…The aim of this analysis was to evaluate adherence of Croatian oncologists to follow‐up criteria as suggested by the current national and international…”
    Get full text
    Journal Article
  4. 4

    Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer - single institution experience by Ban, M, Viculin, J, Tomic, S, Capkun, V, Strikic, A, Mise, B Petric, Utrobicic, I, Vrdoljak, E

    Published in Neoplasma (2016)
    “…Addition of trastuzumab to chemotherapy is the cornerstone of adjuvant treatment of early HER2 positive breast cancer. Clinical trials and metaanalyses of…”
    Get more information
    Journal Article
  5. 5
  6. 6